Photodynamic therapy: Dermatology and ophthalmology as main fields of current applications in clinic

Bio-Medical Materials and Engineering

Volumn 18, Issue 4-5, 2008, Pages 319-327

  Silva, João N ^a   Filipe, Paulo ^a   Morlière, Patrice ^b   Mazière, Jean Claude ^b   Freitas, João P ^a   Gomes, Manuel Marques ^a   Santus, René ^c  

^a HOSPITAL DE SANTA MARIA   (Portugal)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

Author keywords

Actinic keratosis; Age related macular degeneration; Aminolevulinic acid; Basal cell carcinoma; Cutaneous T cell lymphoma; Photodynamic therapy; Squamous cell carcinoma; Verteporfin

Indexed keywords

ACIDS; ACTINIDES; COMPLEXATION; ENDOTHELIAL CELLS; ESTERS; OPTICAL MATERIALS; OXYGEN; PHOTOSENSITIZERS; PLASMONS; PORPHYRINS; SKIN;

ACTINIC KERATOSIS; AGE-RELATED MACULAR DEGENERATION; AMINOLEVULINIC ACID; BASAL CELL CARCINOMA; CUTANEOUS T-CELL LYMPHOMA; SQUAMOUS CELL CARCINOMA; VERTEPORFIN;

PHOTODYNAMIC THERAPY;

AMINOLEVULINIC ACID; FLUOROURACIL; PHOTOFRIN; PLACEBO; PORPHYRIN; PROTOPORPHYRIN; TEMOPORFIN; VERTEPORFIN;

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CHEMOSURGERY; CLINICAL TRIAL; CONFERENCE PAPER; CRYOTHERAPY; CUTANEOUS T CELL LYMPHOMA; CYTOPLASM; ENDOCYTOSIS; ENDOTHELIUM CELL; EPIDERMAL DYSPLASIA; HUMAN; LICHEN PLANUS; LICHEN SCLEROSUS ET ATROPHICUS; LIPID PEROXIDATION; MYOPIA; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; PSORIASIS; RETINA MACULA AGE RELATED DEGENERATION; SCLERODERMA; SKIN DISEASE; SKIN LEISHMANIASIS; SKIN TUMOR; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VASCULAR TUMOR; VISUAL ACUITY;

CLINICAL MEDICINE; DERMATOLOGY; EYE DISEASES; FORECASTING; FRANCE; HUMANS; OPHTHALMOLOGY; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN DISEASES;

EID: 57649227381     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-2008-0546     Document Type: Conference Paper

References (33)

1. N. Basset-Seguin, S. Ibbotson and L. Emtestam, MAL-PDT versus cryotherapy for treatment of primary superficial basal cell carcinoma: results of a five year prospective randomized trial, J. Invest. Dermatol. 126 (2006), 534.
2. K. Berg, Mechanisms of cell damage in photodynamic therapy, in: The Fundamental Bases of Phototherapy, A. Young, H. Honigsmann and G. Jori, eds, OEMF, Milan, 1996, pp. 181-216.
3. C. Berking, T. Herzinger, M.J. Flaig, M. Brenner, C. Borelli and K. Degitz, The efficacy of photodynamic therapy in actinic cheilitis of the lower lip: a prospective study of 15 patients, Dermatol. Surg. 33 (2007), 825-830.
4. V. Caty, Y. Liu, G. Viau and R. Bissonnette, Multiple large surface photodynamic therapy sessions with topical methylaminolaevulinate in PTCH heterozygous mice, Br. J. Dermatol. 154 (2006), 740-742.
5. C.S. Chang and K.P. Chang, Heme requirement and acquisition by extracellular and intracellular stages of Leishmania mexicana amazonesis, Mol. Biochem. Parasitol. 16 (1985), 267-276.
6. T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst. 90 (1998), 889-905.
7. G. Dragieva, J. Hafner, R. Dummer, P. Schmid-Grendelmeier, M. Roos, B.M. Prinz, G. Burg, U. Binswanger and W. Kempf, Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients, Transplantation 77 (2004), 115-121.
8. G. Dragieva, B.M. Prinz, J. Hafner, R. Dummer, G. Burg, U. Binswanger and W. Kempf, A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients, Br. J. Dermatol. 151 (2004), 196-200.
9. K. Gardlo, Z. Horska, C.D. Enk, L. Rauch, M. Megahed, T. Ruzicka and C. Fritsch, Treatment of cutaneous leishmaniasis by photodynamic therapy, J. Am. Acad. Dermatol. 48 (2003), 893-896.
10. M. Gèze, J.M. Gaullier, M. Bazin and R. Santus, Sub-cellular localization of second generation PDT photosensitizers studied by microspectrofluorometry, in: Analytical Use of Fluorescent Probes in Oncology, E. Kohen and J.G. Hirschberg, eds, Plenum Press, New York, 1996, pp. 113-121.
11. F. Ghaffarifar, O. Jorjani, M. Mirshams, M.H. Miranbaygi and Z.K. Hosseini, Photodynamic therapy as a new treatment of cutaneous leishmaniasis, East. Medit. Health J. 12 (2006), 902-908.
12. Y.G. de Graaf, C. Kennedy, R. Wolterbeek, A.F. Collen, R. Willemze, J.N. Bavinck, Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients: results of a randomized-controlled trial, J. Invest. Dermatol. 126 (2006), 569-574.
13. M. Horn, P. Wolf, H.C. Wulf, T. Warloe, C. Fritsch and L.E. Rhodes, Topical methyl aminolevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional therapy, Br. J. Dermatol. 149 (2003), 1242-1249.
14. G. Jori, M. Beltramini, E. Reddie, B. Salvato, A. Pagnan, L. Ziron, L. Tomio and T. Tsanov, Evidence for the major role of plasma lipoproteins as haematoporphyrin carriers, Cancer Lett. 24 (1984), 291-297.
15. C.J. Kelty, N.J. Brown, M.W.R. Reed and R. Ackrod, The use of 5-aminolevulinic acid as a photosensitiser in photodynamic therapy and photodiagnosis, Photochem. Photobiol. Sci. 1 (2002), 158-168.
16. E. Kohen, R. Santus and J.G. Hirschberg, Photobiology, Academic Press, San Diego, CA, 1995, pp. 23-95.
17. S. Mennel, I. Barbazetto, C.H. Meyer, S. Peter and M. Stur, Ocular photodynamic therapy - standard applications and new indications (Part 1), Ophthalmologica 221 (2007), 216-226.
18. C. Morton, S. Campbell, G. Gupta, S. Keohane, J. Lear, I. Zaki, S. Walton, N. Kerrouche, G. Thomas and P. Soto, Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study, Br. J. Dermatol. 155 (2006), 1029-1036.
19. C.A. Morton, M. Horn and J. Leman, A randomised placebo-controlled, European study comparing MAL-PDT with cryotherapy and 5-fluorouracil in subjects with Bowen's disease: results from a 24 months follow-up, Poster presented at the 10th World Congress on Cancer of the Skin, Vienna, 2005.
20. D.M. Pariser, N.J. Lowe, D.M. Stewart, M.T. Jarratt, A.W. Lucky, R.J. Pariser and P.S. Yamauchi, Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial, J. Am. Acad. Dermatol. 48 (2003), 227-232.
21. C.M. Perrett, J.M. McGregor, J. Warwick, P. Karran, I.M. Leigh, C.M. Proby and C.A. Harwood, Treatment of posttransplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapy, Br. J. Dermatol. 156 (2007), 320-328.
22. J.P. Reyftmann, P. Morliere, S. Goldstein, R. Santus, L. Dubertret and D. Lagrange, Interaction of human low density lipoproteins with porphyrins: a spectroscopic study, Photochem. Photobiol. 40 (1984), 721-729.
23. L.E. Rhodes, M.A. de Rie, R. Leifsdottir, R.C. Yu, I. Bachmann, V. Goulden, G.A. Wong, M.A. Richard, A. Anstey and P. Wolf, Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma, Arch. Dermatol. 143 (2007), 1131-1136.
24. U. Schmidt-Erfurt, T. Hasan, E. Gragoudas, T.J. Flotte and R. Birngruber, Vascular targeting in photodynamic occlusion of subretinal vessels, Ophthalmology 101 (1994), 1953-1961.
25. S. Sharfaei, P. Juzenas, J. Moan and R. Bissonnette, Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice, Arch. Dermatol. Res. 294 (2002), 237-242.
26. S. Sharfaei, G. Viau, H. Lui, D. Bouffard and R. Bissonnette, Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice, Br. J. Dermatol. 144 (2001), 1207-1214.
27. J.N. Silva, P. Filipe, P. Morlière, J.-C, Mazière, J.P. Freitas, J.L. Cirne de Castro and R. Santus, Photodynamic therapies: principles and present medical applications, Biomed. Mater. Eng. 16 (2006), S147-S154.
28. I.M. Stender, N. Bech-Thomsen, T. Poulsen and H.C. Wulf, Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless mice, Photochem. Photobiol. 66 (1997), 493-496.
29. R.M. Szeimies, S. Karrer, S. Radakovic-Fijan, A. Tanew, P.G. Calzavara-Pinton, C. Zane, A. Sidoroff, M. Hempel, J. Ulrich, T. Proebstle, H. Meffert, M. Mulder, D. Salomon, H.C. Dittmar, J.W. Bauer, K. Kernland and L. Braathen, Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study, J. Am. Acad. Dermatol. 47 (2002), 258-262.
30. M. Tarstedt, I. Rosdahl, B. Berne, K. Svanberg and A.M. Wennberg, A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp, Acta Derm. Venereol. 85 (2005), 424-428.
31. W.D. Tope, A. Menter, R.A. El-Azhary, N.J. Lowe, M. Jarratt and D.M. Pariser, Comparison of topical methyl aminolevulinate photodynamic therapy versus placebo photodynamic therapy in nodular BCC, J. Eur. Acad. Dermatol. Venereol. 18 (2004), 413-414.
32. C. Vinciullo, T. Elliott, K. Gebauer, L. Spelman and R. Ngyen, MAL-PDT in patients with basal cell carcinoma: results of an Australian multicenter study, Poster presented to the International Skin Cancer Conference 2004, Zurich, 2004.
33. C. Zane, M. Venturini, R. Sala, P. Calzavara-Pinton, Photodynamic therapy with methylaminolevulinate as a valuable treatment option for unilesional cutaneous T-cell lymphoma, Photodermatol. Photoimmunol. Photomed. 22 (2006), 254-258.